Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fish OIL optimal dosE Determination Study
2010-021018-49Phase 2Terminated
- Sponsor
- GWT-TUD
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of eicosapentaenoic acid + docosahexaenoic acid in sepsis and septic shock, sponsored by GWT-TUD. Primary endpoints: Change in SOFA score and Biochemical safety parameters. Started Jan 2012; status: terminated.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on 2010-021018-49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021018-49.